Quercetin and Its Metabolites in Heart Health

Bioactive Food as Dietary Interventions for Cardiovascular Disease

Volumn , Issue , 2013, Pages 217-228

  Hrelia, S ^a   Angeloni, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882904031     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-396485-4.00011-6     Document Type: Chapter

References (40)

1. Angeloni C., Spencer J.P., Leoncini E., Biagi P.L., Hrelia S. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie 2007, 89:73-82.
2. Angeloni C., Leoncini E., Malaguti M., et al. Role of quercetin in modulating rat cardiomyocyte gene expression profile. American Journal of Physiology. Heart and Circulatory Physiology 2008, 294:H1233-H1243.
3. Annapurna A., Reddy C.S., Akondi R.B., Rao S.R. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. Journal of Pharmacy and Pharmacology 2009, 61:1365-1374.
4. Bartekova M., Carnicka S., Pancza D., et al. Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Canadian Journal of Physiology and Pharmacology 2010, 88:465-471.
5. Boesch-Saadatmandi C., Loboda A., Wagner A.E., et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. The Journal of Nutritional Biochemistry 2010, 22:293-299.
6. Comalada M., Ballester I., Bailon E., et al. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochemical Pharmacology 2006, 72:1010-1021.
7. Duarte J., Perez-Palencia R., Vargas F., et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British Journal of Pharmacology 2001, 133:117-124.
8. Egert S., Wolffram S., Bosy-Westphal A., et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. Journal of Nutrition 2008, 138:1615-1621.
9. Emura K., Yokomizo A., Toyoshi T., Moriwaki M. Effect of enzymatically modified isoquercitrin in spontaneously hypertensive rats. Journal of Nutritional Science and Vitaminology (Tokyo) 2007, 53:68-74.
10. Galisteo M., Garcia-Saura M.F., Jimenez R., et al. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Molecular and Cellular Biochemistry 2004, 259:91-99.
11. Gryglewski R.J., Korbut R., Robak J., Swies J. On the mechanism of antithrombotic action of flavonoids. Biochemical Pharmacology 1987, 36:317-322.
12. Han J.J., Hao J., Kim C.H., et al. Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. Journal of Veterinary Medical Science 2009, 71:737-743.
13. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food and Chemical Toxicology 2007, 45:2179-2205.
14. Ikizler M., Erkasap N., Dernek S., Kural T., Kaygisiz Z. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment. Anadolu Kardiyoloji Dergisi 2007, 7:404-410.
15. Jalili T., Carlstrom J., Kim S., et al. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. Journal of Cardiovascular Pharmacology 2006, 47:531-541.
16. Kolchin Iu N., Maksiutina N.P., Balanda P.P., et al. The cardioprotective action of quercetin in experimental occlusion and reperfusion of the coronary artery in dogs. Farmakologiia i Toksikologiia 1991, 54:20-23.
17. Kottra G., Daniel H. Flavonoid glycosides are not transported by the human Na+/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. Journal of Pharmacology and Experimental Therapeutics 2007, 322:829-835.
18. Leckey L.C., Garige M., Varatharajalu R., et al. Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice. Alcoholism, Clinical and Experimental Research 2010, 34:1535-1542.
19. Loke W.M., Proudfoot J.M., Hodgson J.M., et al. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:749-757.
20. Mackraj I., Govender T., Ramesar S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. Journal of Cardiovascular Pharmacology 2008, 51:239-245.
21. Maffei F., Tarozzi A., Carbone F., et al. Relevance of apple consumption for protection against oxidative damage induced by hydrogen peroxide in human lymphocytes. British Journal of Nutrition 2007, 97:921-927.
22. Mao Z., Liang Y., Du X., Sun Z. 3,3',4',5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats. Canadian Journal of Physiology and Pharmacology 2009, 87:720-728.
23. Navarro-Nunez L., Rivera J., Guerrero J.A., et al. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. British Journal of Pharmacology 2009, 158:1548-1556.
24. Rivera L., Moron R., Sanchez M., Zarzuelo A., Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008, 16:2081-2087.
25. Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202:431-438.
26. Wright B., Moraes L.A., Kemp C.F., et al. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. British Journal of Pharmacology 2010, 159:1312-1325.
27. Xu Y.C., Leung S.W., Yeung D.K., et al. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. Phytochemistry 2007, 68:1179-1188.
28. Yoshizumi M., Tsuchiya K., Kirima K., et al. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Molecular Pharmacology 2001, 60:656-665.
29. Yoshizumi M., Tsuchiya K., Suzaki Y., et al. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical and Biophysical Research Communications 2002, 293:1458-1465.
30. You K.M., Jong H.G., Kim H.P. Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Archives of Pharmacal Research 1999, 22:18-24.
31. Bischoff S.C. Quercetin: potentials in the prevention and therapy of disease. Current Opinion in Clinical Nutrition and Metabolic Care 2008, 11:733-740.
32. Boots A.W., Li H., Schins R.P., et al. The quercetin paradox. Toxicology and Applied Pharmacology 2007, 222:89-96.
33. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology 2008, 585:325-337.
34. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Natural Product Reports 2009, 26:1001-1043.
35. Moon Y.J., Wang L., DiCenzo R., Morris M.E. Quercetin pharmacokinetics in humans. Biopharmaceutics and Drug Disposition 2008, 29:205-217.
36. Murota K., Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Archives of Biochemistry and Biophysics 2003, 417:12-17.
37. Nikolic M., Nikic D., Petrovic B. Fruit and vegetable intake and the risk for developing coronary heart disease. Central European Journal of Public Health 2008, 16:17-20.
38. Perez-Vizcaino F., Duarte J. Flavonols and cardiovascular disease. Molecular Aspects of Medicine 2010, 31:478-494.
39. Perez-Vizcaino F., Duarte J., Jimenez R., Santos-Buelga C., Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacological Reports 2009, 61:67-75.
40. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radical Biology and Medicine 2004, 36:838-849.